| Name | Title | Contact Details |
|---|
Brightline is the first full-family behavioral health solution built specifically to care for kids, teens, and parents across a range of common family challenges. Launched at a time when 1 in 5 children has a behavioral health condition and up to 80% don't get the care they need, with increasing need exacerbated by the Covid-19 pandemic, Brightline is here to help families across the country thrive. With multidisciplinary care teams, personalized family system care, evidence-based care delivery, and extraordinary technology, Brightline is able to support families with whatever challenges they’re facing and ultimately help them thrive long-term. With Brightline, families can access support for a range of needs with our digital platform that includes resources and education for parents, interactive treatment exercises, and more; 1:1 coaching to support kids, teens, and parents with skill-building and guidance for dealing with tough stuff; behavior therapy, medication support, and speech therapy for a range of behavioral and developmental health needs. All right from home, right when families need it most. Join us to bring extraordinary care to families across the country!
Relmada Therapeutics (OTCQB: RLMD) is a clinical-stage, publicly traded specialty pharmaceutical company developing novel versions of proven drug products together with new chemical entities that potentially address areas of high unmet medical need in the treatment of chronic pain. Relmada has a diversified portfolio of four lead products at various stages of development including d-Methadone (REL-1017) its N-methyl-D-aspartate (NMDA) receptor antagonist for neuropathic pain; topical mepivacaine (REL-1021), its orphan drug designated topical formulation of the local anesthetic mepivacaine; oral buprenorphine (REL-1028) its oral dosage form of the opioid analgesic buprenorphine; and LevoCap ER (REL-1015), its abuse resistant, sustained release dosage form of the opioid analgesic levorphanol. Relmada`s product development efforts are guided by the internationally recognized scientific expertise of our research team. Relmada`s approach is expected to reduce clinical development risks and costs while potentially delivering valuable products in areas of high unmet medical needs.
Brauer and Associates is a Elmhurst, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Acumen is a Burlingame, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
TeamHealth Medical Call Center is a Knoxville, TN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.